FDA Approves New Treatment for Pneumonia Caused by Drug-Resistant Bacteria
The U.S. Food and Drug Administration announced it recently approved Xacduro (sulbactam for injection; durlobactam for injection), a new treatment for hospital-acquired bacterial pneumonia (HABP) and ventilator-associated bacterial pneumonia (VABP) …
FDA Approves New Treatment for Pneumonia Caused by Drug-Resistant Bacteria Read More